You're reading everything related to:
Key Insights From The Pharmaceutical Cannabis Report
Key Insights From CBD: The Consumer Report
CBD: The Consumer Report is the latest release in the suite of Prohibition Partners’ market-leading consumer research reports, providing proprietary data on over 15,000 adults from seven key global markets,...
Synthetic cannabinoid firm’s stock tanks 77% after failed clinical trials
Corbus Pharmaceuticals, one of the leaders in the pharmaceutical cannabinoid industry takes a hit as their lead drug fails in advanced clinical trials.
Australian medical cannabis approvals rising despite COVID-19 disruptions
After a quarter of stalled growth, approvals for cannabis-based medicines via the SAS-B route is now accelerating once more.
Europe is recording one million cannabis offences a year
Drug offences involving cannabis are following a stable, albeit slightly rising trend in Europe, which registers over one million cannabis offences each year, despite the fact that over 25 million...
Product testing in Australia reveals inconsistencies over cannabinoid potency
Last Friday, Australian regulator TGA published test results on the most common medical cannabis products sold in Australia. Results, which showed 23% of products had cannabinoid levels which differed from...
Prohibition Partners LIVE returns this November with global cannabis conference
Cannabis market set to offer welcome relief during global recession
European Cannabis: Waking The Sleeping Giant
The consolidation of fully legalised and regulated cannabis industries in North America has powered hope that the same progressive systems might be implemented as quickly and successfully elsewhere. However, the...
Prohibition Partners Interviews Pharmin’s CEO Ana Kobalia
Pharmin is a vertically integrated Uruguayan company, formed in June 2019 as a result of a transnational partnership of experienced and successful entrepreneurs. Today, the company is proud of its...
Germany: Insured medicinal cannabis sales worth €75 million in the first half of 2020
New data just released from the National Association of Statutory Health Insurance Funds (GKV) shows continued year on year growth of the German medicinal cannabis market, despite signs that growth...
Recreational cannabis projects beginning to emerge in Europe
Prohibitionist ideologies embedded in the international narcotic treaties have hampered the development of legal recreational cannabis programmes in Europe. However, we have seen the emergence of cannabis social clubs and...
Prohibition Partners interviews cannabinoid expert D'Arcy Bond from Newell Sciences
Newell Sciences is a fully integrated cannabinoid producer that delivers high quality cannabinoids to the global market. Prohibition Partners sits down with D’Arcy Bond, Director of Newell Sciences, to discuss...
US Congressional Committee Approves the Medical Cannabis Research Act
Key insights from THE IMPACT SERIES: Disrupting Food
Israeli cannabis patient numbers reach 60,000 as imports are on course to dominate domestic market
Cannabis patient numbers in Israel have reached a record high in 2020, breaking the 60,000 mark. However, compliance issues for local producers have hamstrung the domestic market with imports rising...
Medical cannabis patient numbers reach 20,000 in Brazil
Individual patient authorisations to import cannabis products into Brazil continue to surge, as shown by the most recent data provided by Brazilian health regulator ANVISA to Prohibition Partners.
Medical growers planning over 300 tonnes of European-grown cannabis
For the majority of the previous two decades, the Netherlands was responsible for the sole commercial cultivation of cannabis in Europe. Now, half a dozen European states produce cannabis for...
Clarification: Is Cannabis a Cure for COVID?
Currently, over 22 million people have been infected with COVID-19 worldwide and researchers estimate that it will take months before we have medicines that effectively treat or cure the virus...
European medical cannabis trade: Southern Europe becoming largest supplier
The rising demand for medical cannabis in Europe, driven primarily by maturing markets such as Germany, Italy and the Netherlands, has opened the door to new sources for medical cannabis...
Hemp farming in the US: total acreage shrinks for the first time
Is the age of exponential growth in hemp farming coming to an end? If so, what does this mean for the supply-demand balance of the CBD industry? With CBD gradually...
Over 30% of adults in Europe and North America willing to try infused beverages
Proprietary consumer surveys from Prohibition Partners show that a significant proportion of the adult populations in Europe’s major cannabis markets and North America are willing to try infused beverages.
July records largest single-month patient growth in Australia as authorisations surge
Earlier today, the TGA of Australia released data on medical cannabis authorisations for July, showing the largest single month increase in prescription approvals to date.
Social Listening: Positive sentiment dominant ahead of New Zealand referendum
Recent online sentiment analysis has suggested cannabis legislation is now being viewed favourably by citizens in New Zealand.
Argentina announces plans to broaden medical cannabis schemes
Argentina has drafted regulations to increase accessibility to medicinal cannabis in 2020, allowing more patients to get access.
Germany imports 4,126kg of medical cannabis during the first half of 2020
Yesterday, Germany’s BfArM released new data on medical cannabis imports from Q1 and Q2 2020, showing an increase of 16% in Q1 2020 and 32% in Q2 2020.
Canadian legal cannabis sales set to surpass CAD$2 billion in 2020 and outpace illegal production
According to StatsCan, Canadian retailers sold a record CAD$185.9 million worth of cannabis in May 2020.
FDA set to launch widespread CBD testing plan to tackle product inconsistencies
Earlier this month, the US FDA released data on the US CBD market as part of a review by the White House relating to cannabis and CBD research.
UK CBD market facing shake up as prices drop and premium CPG brands set to emerge
Over the last two years, the UK CBD market has enjoyed low barriers to entry, a lack of regulatory standards and extremely high premiums for inconsistent high street products.
Deputy Ministers submit proposal to legalise adult-use cannabis in Guernsey
Two Deputy Ministers have submitted proposals to fully legalise recreational cannabis, with the hope of implementing an operating model similar to the one used in Canada.
Medical Cannabis Prescriptions Grow 400% year-on-year in the Czech Republic
Czech Republic passes 1,000 monthly patients mark as flower prescriptions grow 400% year-on-year
Overcapacity continues to loom over the Canadian market despite players slashing costs
Despite increasing demand, both in the medical and adult-use markets, inventory figures continued to increase in tandem, leading to an oversupply in the Canadian market.
Cannabis 2.0 boosts legal cannabis sales in Canada
Health Canada has resumed the publication of monthly data on the Canadian market, showing a steady increase in medical cannabis sales since October 2019.
Key Insights from The Impact Series: Disrupting Drinks
Disrupting Drinks is the latest report in The Impact Series — Prohibition Partners’ suite of in-depth reports detailing the impact of cannabis across key consumer markets — and the first...